Milestone Pharmaceuticals

MIST53

Penny Stock

$1.87arrow_drop_up1.08%$0.02

Penny Stock

MIST53

$1.87

arrow_drop_up1.08%$0.02

Penny Stock

Performance History

Key Stats
Open	$1.84
Prev. Close	$1.85
EPS	-0.80
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$99.72M
PE Ratio	-

	LOW	HIGH
Day Range	1.85	1.98
52 Week Range	1.12	3.52

Ratios







EPS	-0.80

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc (MIST) is a pharmaceutical company that focuses on the development of innovative therapies for various cardiovascular conditions. The company is committed to improving the lives of patients by discovering and delivering breakthrough treatments that address significant unmet medical needs. MIST is dedicated to advancing the field of cardiovascular medicine through its research and development efforts.

As of the latest available data, Milestone Pharmaceuticals Inc has a market capitalization of XYZ. The company's stock price history shows fluctuations over time, reflecting market trends and investor sentiment. Investors interested in MIST can stay updated on the latest stock price by monitoring financial news sources or accessing online trading platforms.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Joseph G. Oliveto M.B.A.
Headquarters: Montreal
Employees: 39
Exchange: NASDAQ

add Milestone Pharmaceuticals to watchlist

Keep an eye on Milestone Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Milestone Pharmaceuticals 's (MIST) price per share?

The current price per share for Milestone Pharmaceuticals (MIST) is $1.87. The stock has seen a price change of $0.02 recently, indicating a 1.08% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Milestone Pharmaceuticals (MIST)?

For Milestone Pharmaceuticals (MIST), the 52-week high is $3.52, which is 88.24% from the current price. The 52-week low is $1.12, the current price is 66.96% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Milestone Pharmaceuticals (MIST) a growth stock?

Milestone Pharmaceuticals (MIST) has shown an average price growth of -2.69% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Milestone Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Milestone Pharmaceuticals (MIST) stock price performance year to date (YTD)?

As of the latest data, Milestone Pharmaceuticals (MIST) has a year-to-date price change of 3.89%. Over the past month, the stock has experienced a price change of 28.97%. Over the last three months, the change has been 27.21%. Over the past six months, the figure is 13.33%. Looking at a longer horizon, the five-year price change stands at -89.06%.

help

Is Milestone Pharmaceuticals (MIST) a profitable company?

Milestone Pharmaceuticals (MIST) has a net income of -$59.68M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1M, although specific revenue growth data is currently not available. The gross profit is $1M. Operating income is noted at -$61.1M. Furthermore, the EBITDA is -$49.19M.

help

What is the market capitalization of Milestone Pharmaceuticals (MIST)?

Milestone Pharmaceuticals (MIST) has a market capitalization of $99.72M. The average daily trading volume is 1.88, indicating the stock's liquidity and investor engagement.

News

MILESTONE PHARMACEUTICALS

JI XING PHARMACEUTICALS

ETRIPAMIL

PSVT

Sep 6, 2024

Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China

MILESTONE PHARMACEUTICALS

JOSEPH PAPA

CARDAMYST

PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Sep 4, 2024

Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors

CALENDAR OF EVENTS

Jun 12, 2024

Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS

May 31, 2024

Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference

HEALTH

CLINICAL STUDY

May 29, 2024

Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™

May 16, 2024

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know